Major Job Cuts At Merck in Ireland, Forest Labs
Merck announced this week that it plans to close a plant in Ireland at the end of 2017, which is going to cut almost 600 jobs. The closure of the plant in Swords, Co Dublin is because of the review of the company’s manufacturing needs around the world indicated that the plant was no longer […]
Read More »Category : News
Main Wockhardt Drug Plant in India Banned by FDA
Wockhardt Ltd. is now banned from selling several drugs in the US from another factor in India, after FDA inspectors added it to a restricted list. This caused the company’s stock to drop 14%. The Wockhardt facility in Aurangabad, which is its highest revenue producer, was added to FDA’s red list last week. This means […]
Read More »Category : News
DNA Test Maker Hit With Nasty Warning Letter
FDA last week ordered the DNA testing firm 23andMe to cease selling its OTC generic DNA test, stating that it is being sold without FDA approval to diagnose diseases. The DNA test, which has been heavily marketed in recent months, has a kit to sample your saliva, and the firm promises that it will offer […]
Read More »Category : News
HHS OPDP Letter Rips Kadmon Pharmaceuticals for Marketing Claims
The Office Of Prescription Drug Promotion has sent a nasty warning letter to Kadmon Pharmaceuticals this month. The Department of Health and Human Services agency, which must ensure that drugmakers’ claims do not go too far, sent a stern warning letter to Kadmon regarding a letter that it sends out with the Ribasphere RibaPak. OPDP […]
Read More »Category : News
Layoffs Continue in Pharma in November
Earlier in 2013, Merck, Astrazeneca and Eli Lilly announced restructuring that has led to disappearing jobs. Much of the cuts were related to poor clinical trial results and revenues that were dropping because of generic competition. This week, Novartis, Bristol Myers Squibb and Ariad have announced that they also are cutting jobs. At Novartis, the […]
Read More »Category : News
J&J to Pay $2.5 Billion to Settle Hip Replacement Lawsuit
Johnson & Johnson this week stated that it will agree to pay out $2.5 billion to settle tens of thousands of suits from hip replacement patients who say that they were sold implants that were faulty that caused injuries and more surgeries. The agreement will bring to an end about 8000 cases of patients who […]
Read More »Category : News
Merck Ends API Production at Plant in Puerto Rico
Merck announced last week that it was ending API production at one of its key plants in Puerto Rico. This is a major blow to the city of Barceloneta, which was once considered a major pharmaceutical hub there. Merck stated that the production at the plant will be ended in 2014, as part of a […]
Read More »Category : News
Chicago Government Issues Subpoena to J&J in Investigation
The Rahm Emmanuel administration is conducting an investigation into a branch of Johnson & Johnson for allegedly engaging in deceptive marketing of painkillers to employees of the City of Chicago. This information is according to a petition that was filed in Cook County Circuit Court, which is trying to force the company to divulge six […]
Read More »Category : News
House of Representatives To Grill FDA on FDASIA
A year has passed since Congress passed the Food and Drug Administration Safety and Innovation Act (FDASIA) act. Now, legislators are wondering how the law is doing, and an upcoming hearing this week answer some questions that Congress has. FDASIA was passed in 2012, and has provisions that include both user fee programs and reforms. […]
Read More »Category : News
Another Nasty 483 for Hospira
Hospira this week got another 483, this time for three cGMP violations for its plant in Kansas. Most of the focus on Hospira has been with the Rock Mount NC plant and all of the problems and warning letters it has gotten from FDA. But CEO Michael Ball also told stakeholders last week about a […]
Read More »Category : News
